뉴스
-
Samsung Bio·VUNO Fall on Rights Offerings…SHINPOONG·CHO-A↑[K-Bio Pulse]
On Aug. 28, major pharmaceutical and biotech companies saw mixed stock performances as investors responded to various corporate events.Samsung Biologics shares plunged 6.78% following the company&rsq...
www.edaily.co.kr · 2026.08.29
-
DRTech·TissueGene·Finemedix, All Rally [K-bio Pulse]
On the 13th, three names in Korea's pharmaceutical, biotech and healthcare sector — DRTech, KolonTissueGene DR Tech and FinemediX rose on the back of imp...
www.edaily.co.kr · 2026.08.14
-
Biotech Stocks Rally with Market Rebound; Orum Therapeutics Jumps 18% [K-Bio Pulse]
, with bargain hunting returning to beaten-down growth and biotech names. While many of the d...
www.edaily.co.kr · 2026.08.01
-
Market Fluctuates, Daehwa Pharm, LabGenomics, and NeoImmuneTech Rise[K-Bio Pulse]
On the 7th, amid mixed trading in the South Korean stock market, pharmaceutical and biotech companies
www.edaily.co.kr · 2026.08.10
-
FromBio Hits Limit-Up as Trading Resumes; Curacle Surges on Follow-On Licensing Hopes [K-Bio Puls...
On Aug. 10, South Korean pharmaceutical and biotech stocks broadly advanced as the KOSDAQ rebounded. FromBio soared to the daily upper limit as trading resumed following a 5-for-1 reverse stock split...
www.edaily.co.kr · 2026.08.11
-
[K-Bio Pulse]Biotech Stocks Defy 'Black Tuesday' as MedPacto Soars, Bioinfra Faces Dead...
Despite the "Black Tuesday" selloff on July 28, several biotech stocks bucked the broader market. As the Kosdaq tumbled, Cellid, Bioinfra, and MedPacto all hit the daily upper limit.
www.edaily.co.kr · 2026.07.29
-
Rokit, AprilBio Hit Limit-Up...HanAll Jumps on Own Catalyst[K-Bio Pulse]
The biotech and healthcare sector saw a rare wave of positive momentum on June 24, helped by sentiment surrounding the 2026 BIO International Convention, or BIO USA, the world’s largest biotech...
www.edaily.co.kr · 2026.06.25
-
Remedi Surges, HLB Hits Limit Down as FDA Blow Weighs[K-Bio Pulse]
The Korean biotech sector saw sharply diverging performances on July 13, with newly listed Remedi. emerging as the day's standout performer, while HLB extended its selloff following another U.S.
www.edaily.co.kr · 2026.07.14
-
Lemon Healthcare Rebounds to Limit-Up on Second Trading Day; D&D Pharmatech, PharmaResearch Also ...
South Korea's pharmaceutical and biotech sector posted broad gains on Tuesday despite heightened market volatility that triggered a sell-side sidecar on the benchmark stock market early in the sessio...
www.edaily.co.kr · 2026.07.08
-
Peptron Sinks on Fading Lilly Hopes; Nature Cell, BL Pharmtech Hit Limit-Up [K-Bio Pulse]
On July 9, South Korean pharmaceutical and biotech stocks saw sharply divergent moves, with Nature Cell and BL Pharmtech both hitting the daily upper limit, while Peptron tumbled to the lower limit i...
www.edaily.co.kr · 2026.07.10
뉴스 결과 더보기 →
블로그
-
[NMPA] China updates drug clinical trial guideline to enhance biotech innovation
on Monday, the guideline updates the previous version that had been in effect since 2020. According to the administration, the revision .......
blog.naver.com · 2026.06.15
-
앤퀘르세틴 어떤 효능이 있을까
SN Biotech Co.,Ltd 체지방 감소효과 Enzymatically Modified Isoquercitrin(EMIQ)은 항비만·근기능 강화·이너뷰티를 포함하는 폭넓은 건강 Anti-obesity effects of heat-transformed green tea extract through the activation of adipose tissue thermogenesis
blog.naver.com · 2026.02.20
-
가장 큰 상승 잠재력을 가진 12개 바이오텍 미국 주식/RVMD/IONS/FOLD/DNLI/CRSP/RARE/CRNX/IMVT/MRUS/RNA/LEGN/VKTX
가장 큰 상승 잠재력을 가진 12개 바이오텍 주식 12 Biotech Stocks with the Biggest Upside Potential 원문 : https://www.insidermonkey.com /blog/12-biotech-stocks-with-the-biggest-upside-potential-1425221/?
blog.naver.com · 2025.01.18
-
Electroceutical device uses light to improve blood flow in the brain, alleviating dementia symptoms
Dementia is the most common degenerative brain disease associated with aging. The main cause of dementia.......
blog.naver.com · 2023.08.08
-
Autophagy: Drugging the yin and yang of the cell
Can biotech companies walk the fine line between boosting and inhibiting autophagy to treat disease without After the Nobel Prize was awarded for the discovery of autophagy genes in 2016, several biotech companies
blog.naver.com · 2021.02.21
-
[공유]정부, 코로나19 치료제·백신 개발에 1936억 원 투입
Maryland biotech company. In May, the government awarded more than $1.2 billion to pharmace.......
blog.naver.com · 2020.07.09
-
제넥신, 코로나 백신 관련 뉴스, 내년 2분기 백신 시판 가능할 것
South Korea’s biotech firm Genexine will be able to market vaccine to prevent COVID-19 in the second half of next year, given the pace of simultaneous clinical trials in multiple countries, said the compa
blog.naver.com · 2020.06.18
-
Coronavirus treatment: Vaccines/drugs in the pipeline for COVID-19
The pandemic has catalysed the development of novel coronavirus vaccines across the biotech industry, The first COVID-19 vaccine in China is expected to be ready for clinical trials by the end of April,
blog.naver.com · 2020.03.23
-
LABU
The fund normally creates long positions by investing at least 80% of its assets in the securities that comprise the index and/or financial instruments that provide leveraged and unleveraged exposure to the
blog.naver.com · 2017.02.19
-
Clinical Comparison of the Treponema pallidum CAPTIA Syphilis-G Enzyme Immunoassay with the Fluoresc
) IgG assay were evaluated by the CAPTIA EIA. (RPR) testing of the same specimens.
blog.naver.com · 2016.11.21
블로그 결과 더보기 →